Unknown

Dataset Information

Aptamers against mouse and human tumor-infiltrating myeloid cells as reagents for targeted chemotherapy.


ABSTRACT: Local delivery of anticancer agents has the potential to maximize treatment efficacy and minimize the acute and long-term systemic toxicities. Here, we used unsupervised systematic evolution of ligands by exponential enrichment to identify four RNA aptamers that specifically recognized mouse and human myeloid cells infiltrating tumors but not their peripheral or circulating counterparts in multiple mouse models and from patients with head and neck squamous cell carcinoma (HNSCC). The use of these aptamers conjugated to doxorubicin enhanced the accumulation and bystander release of the chemotherapeutic drug in both primary and metastatic tumor sites in breast and fibrosarcoma mouse models. In the 4T1 mammary carcinoma model, these doxorubicin-conjugated aptamers outperformed Doxil, the firs

SUBMITTER: De La Fuente A 

PROVIDER: S-EPMC9281582 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature